Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4727
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbdiaxatov Sh.Z. Kurbonova Z.Ch.-
dc.date.accessioned2022-12-03T05:51:23Z-
dc.date.available2022-12-03T05:51:23Z-
dc.date.issued2021-12-29-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/4727-
dc.description.abstractGematologik kasalliklar hisoblangan leykozlar an'anaviy kimyoterapiyaning kam selektivligi tufayli juda ko'p qiyinchiliklarga duch keladi, terapevtik samaradorligi past va ko'plab salbiy ta'sirlarga ega. Nanomedicina esa saratonga qarshi dorilarning samaradorligini oshirish, toksikligini kamaytirish, davolash dinamikasini kuzatish imkoniyatini beradi. Nanozarrachalar biomarkerlarni va tahlillarni aniqlashni soddalashtiradi, nanomedicinaning eng asosiy muvaffaqiyati esa haqiqiy inson bemorlarda qo’llash imkoniyati mavjudligidadir. Nanotexnologiya shu qadar rivojlanganki, u leykemiya va limfomalarni davolashda biomarkerlarni aniqlash va maqsadli davolashga yordam beradi, to'g'ri terapevtik rejimni tanlashga yordam beradi.en_US
dc.language.isootheren_US
dc.publisherTashkenten_US
dc.subjectGippokrat,karsinoma,Selk,onkos,Galen,saratonen_US
dc.titleNanotexnologiya bilan davolash imkoniyatlarien_US
dc.typeThesisen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
2021 TIBBIY TALIM megatrendlar Нанотехнология.pdf1.34 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.